HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar.

Dorian CulieAlexandra RousseauJean-Luc PretetJean Lacau Saint Guily

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021)

5-year follow-up confirms the specifically improved prognosis in HPV-positive patients. The prognosis is nevertheless significantly modified through clinical and therapeutical variations.

Keyphrases

end stage renal disease
high grade
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
metabolic syndrome
prostate cancer
young adults
skeletal muscle
childhood cancer